{"database": "openregs", "table": "documents", "rows": [["FDA-2015-N-1260-0008", "FDA", "FDA-2015-N-1260", "Fixed-Combination and Co-Packaged Drugs: Applications for Approval and Combinations of Active Ingredients Under Consideration for Inclusion in an Over-the-Counter Monograph Proposed Rule; Reopening of the Comment Period", "Proposed Rule", "Reopening of Comment Period", "2016-04-18T04:00:00Z", 2016, 4, "2016-04-18T04:00:00Z", "2016-05-19T03:59:59Z", "2016-05-18T22:00:30Z", "2016-08888", 0, 0, "0900006481f70598"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2015-N-1260-0008"], "units": {}, "query_ms": 0.378910917788744, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}